Long noncoding RNA SATB1-AS1 contributes to the chemotherapy resistance through the microRNA-580/ 2’-5’-oligoadenylate synthetase 2 axis in acute myeloid leukemia

References

• Dohner H, Weisdorf DJ, Bloomfield CD. Acute myeloid leukemia. N Engl J Med. 2015;373(12):1136–1152.
   PubMed Web of Science ®Google Scholar
• Lynch RC, Medeiros BC. Chemotherapy options for previously untreated acute myeloid leukemia. Expert Opin Pharmacother. 2015;16(14):2149–2162.
   PubMed Web of Science ®Google Scholar
• Estey EH. Acute myeloid leukemia: 2019 update on risk-stratification and management. Am J Hematol. 2018;93(10):1267–1291.
   PubMed Web of Science ®Google Scholar
• Maruyama R, Suzuki H. Long noncoding RNA involvement in cancer. BMB Rep. 2012;45:604–611.
   PubMed Web of Science ®Google Scholar
• Ayers D, Vandesompele J. Influence of microRNAs and long non-coding RNAs in cancer chemoresistance. Genes (Basel). 2017;8(3):95.
   PubMed Web of Science ®Google Scholar
• Yang Y, Dai W, Sun Y, et al. Long noncoding RNA linc00239 promotes malignant behaviors and chemoresistance against doxorubicin partially via activation of the PI3K/Akt/mTOR pathway in acute myeloid leukaemia cells. Oncol Rep. 2019;41:2311–2320.
   PubMed Web of Science ®Google Scholar
• Li Q, Song W, Wang J. TUG1 confers Adriamycin resistance in acute myeloid leukemia by epigenetically suppressing miR-34a expression via EZH2. Biomed Pharmacother. 2019;109:1793–1801.
   PubMed Web of Science ®Google Scholar
• Dong X, Fang Z, Yu M, et al. Knockdown of Long noncoding RNA HOXA-AS2 suppresses chemoresistance of acute myeloid leukemia via the miR-520c-3p/S100A4 axis. Cell Physiol Biochem. 2018;51(2):886–896.
   PubMedGoogle Scholar
• Shademan M, Naseri Salanghuch A, Zare K, et al. Expression profile analysis of two antisense lncRNAs to improve prognosis prediction of colorectal adenocarcinoma. Cancer Cell Int. 2019;19(1):278.
   PubMed Web of Science ®Google Scholar
• Salmena L, Poliseno L, Tay Y, et al. A ceRNA hypothesis: the Rosetta Stone of a hidden RNA language? Cell. 2011;146(3):353–358.
   PubMed Web of Science ®Google Scholar
• Dick FR, Armitage JO, Burns CP. Diagnostic concurrence in the subclassification of adult acute leukemia using French-American-British criteria. Cancer. 1982;49(5):916–920.
   PubMed Web of Science ®Google Scholar
• Jeck WR, Sharpless NE. Detecting and characterizing circular RNAs. Nat Biotechnol. 2014;32(5):453–461.
   PubMed Web of Science ®Google Scholar
• Endo H, Owada S, Inagaki Y, et al. Glucose starvation induces LKB1-AMPK-mediated MMP-9 expression in cancer cells. Sci Rep. 2018;8(1):10122.
   PubMedGoogle Scholar
• Telford WG. Multiparametric analysis of apoptosis by flow cytometry. Methods Mol Biol. 2018;1678:167–202.
   PubMedGoogle Scholar
• Keilhack H, Chang P. In vitro long-term proliferation assays to study antiproliferative effects of PARP inhibitors on cancer cells. Methods Mol Biol. 2017;1608:321–336.
   PubMedGoogle Scholar
• Flomerfelt FA, Gress RE. Analysis of cell proliferation and homeostasis using EdU labeling. Methods Mol Biol. 2016;1323:211–220.
   PubMedGoogle Scholar
• Broussas M, Broyer L, Goetsch L. Evaluation of antibody-dependent cell cytotoxicity using lactate dehydrogenase (LDH) measurement. Methods Mol Biol. 2013;988:305–317.
   PubMedGoogle Scholar
• Zaleskis G, Garberyte S, Pavliukeviciene B, et al. Doxorubicin uptake in ascitic lymphoma model: resistance or curability is governed by tumor cell density and prolonged drug retention. J Cancer. 2020;11(22):6497–6506.
   PubMed Web of Science ®Google Scholar
• Zhang X, Zhang Z, Zhang Q, et al. ZEB1 confers chemotherapeutic resistance to breast cancer by activating ATM. Cell Death Dis. 2018;9(2):57.
   PubMedGoogle Scholar
• Li X, Zhang Y, Zheng L, et al. UTX is an escape from X-inactivation tumor-suppressor in B cell lymphoma. Nat Commun. 2018;9(1):2720.
   PubMedGoogle Scholar
• Piya S, Kornblau SM, Ruvolo VR, et al. Atg7 suppression enhances chemotherapeutic agent sensitivity and overcomes stroma-mediated chemoresistance in acute myeloid leukemia. Blood. 2016;128(9):1260–1269.
   PubMed Web of Science ®Google Scholar
• Ma HL, Jin SF, Ju WT, et al. Stathmin is overexpressed and regulated by mutant p53 in oral squamous cell carcinoma. J Exp Clin Cancer Res. 2017;36:109.
   PubMed Web of Science ®Google Scholar
• Tanaka C, Uzawa K, Shibahara T, et al. Expression of an inhibitor of apoptosis, survivin, in oral carcinogenesis. J Dent Res. 2003;82:607–611.
   PubMed Web of Science ®Google Scholar
• Dunagin M, Cabili MN, Rinn J, et al. Visualization of lncRNA by single-molecule fluorescence in situ hybridization. Methods Mol Biol. 2015;1262:3–19.
   PubMedGoogle Scholar
• Jin Y, Chen Z, Liu X, et al. Evaluating the microRNA targeting sites by luciferase reporter gene assay. Methods Mol Biol. 2013;936:117–127.
   PubMedGoogle Scholar
• Haniu H, Watanabe D, Kawashima Y, et al. Two-dimensional gel-based protein standardization verified by western blot analysis. Methods Mol Biol. 2015;1312:473–479.
   PubMedGoogle Scholar
• Medeiros BC. Long non-coding RNAs: another brick in the wall of normal karyotype acute myeloid leukemia? Haematologica. 2017;102(8):1301–1303.
   PubMed Web of Science ®Google Scholar
• Murphy T, Yee KWL. Cytarabine and daunorubicin for the treatment of acute myeloid leukemia. Expert Opin Pharmacother. 2017;18:1765–1780.
   PubMed Web of Science ®Google Scholar
• Bachas C, Schuurhuis GJ, Zwaan CM, et al. Gene expression profiles associated with pediatric relapsed AML. PLoS One. 2015;10:e0121730.
   PubMed Web of Science ®Google Scholar
• Nairismagi ML, Vislovukh A, Meng Q, et al. Translational control of TWIST1 expression in MCF-10A cell lines recapitulating breast cancer progression. Oncogene. 2012;31:4960–4966.
   PubMed Web of Science ®Google Scholar
• Tang G, Liu L, Xiao Z, et al. CircRAB3IP upregulates twist family BHLH transcription factor (TWIST1) to promote osteosarcoma progression by sponging miR-580-3p. Bioengineered. 2021;12:3385–3397.
   PubMed Web of Science ®Google Scholar
• Gonzalez KJ, Moncada-Giraldo DM, Gutierrez JB. In silico identification of potential inhibitors against human 2ʹ-5ʹ- oligoadenylate synthetase (OAS) proteins. Comput Biol Chem. 2020;85:107211.
   PubMed Web of Science ®Google Scholar
• Zhao L, Zhang X, Wu Z, et al. The Downregulation of MicroRNA hsa-miR-340-5p in IAV-Infected A549 Cells Suppresses Viral Replication by Targeting RIG-I and OAS2. Mol Ther Nucleic Acids. 2019;14:509–519.
   PubMedGoogle Scholar
• Sun S, Li Y, Han S, et al. A comprehensive genome-wide profiling comparison between HBV and HCV infected hepatocellular carcinoma. BMC Med Genomics. 2019;12:147.
   PubMed Web of Science ®Google Scholar
• Liu X, Heng C, Li Y, et al. MiR-302a sensitizes leukemia cells to etoposide by targeting Rad52. Oncotarget. 2017;8:73884–73891.
   PubMedGoogle Scholar
• Huang L, Chen J, Quan J, et al. Rosmarinic acid inhibits proliferation and migration, promotes apoptosis and enhances cisplatin sensitivity of melanoma cells through inhibiting ADAM17/EGFR/AKT/GSK3beta axis. Bioengineered. 2021;12:3065–3076.
   PubMed Web of Science ®Google Scholar
• Wu D, Liu L, Yan X, et al. Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein. Oncotarget. 2017;8:63857–63870.
   PubMedGoogle Scholar
• Li C, Xin H, Shi Y, et al. Knockdown of TRIM24 suppresses growth and induces apoptosis in acute myeloid leukemia through downregulation of Wnt/GSK-3beta/beta-catenin signaling. Hum Exp Toxicol. 2020;39:1725–1736.
   PubMed Web of Science ®Google Scholar